Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Lindh

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Molecular Pharmaceutics|March 25, 2017
Predicting the Rate of Skin Penetration Using an Aggregated Conformal Prediction FrameworkMartin Lindh, Anders Karlén, Ulf Norinder
Journal of Chemical Information and Modeling|January 8, 2015
Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS dataMartin Lindh, Fredrik Svensson, Wesley Schaal, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosisMounir Andaloussi, Martin Lindh, Christofer Björkelid, et al.
Journal of Medicinal Chemistry|February 29, 2012
Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitorsJohan Gising, Mikael T Nilsson, Luke R Odell, et al.
Journal of Medicinal Chemistry|June 18, 2011
Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomeraseMounir Andaloussi, Lena M Henriksson, Anna Więckowska, et al.
Journal of Medicinal Chemistry|July 4, 2013
DXR inhibition by potent mono- and disubstituted fosmidomycin analoguesAnna M Jansson, Anna Więckowska, Christofer Björkelid, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Molecular Pharmaceutics|March 25, 2017
Predicting the Rate of Skin Penetration Using an Aggregated Conformal Prediction FrameworkMartin Lindh, Anders Karlén, Ulf Norinder
Journal of Chemical Information and Modeling|January 8, 2015
Toward a benchmarking data set able to evaluate ligand- and structure-based virtual screening using public HTS dataMartin Lindh, Fredrik Svensson, Wesley Schaal, et al.
Bioorganic & Medicinal Chemistry Letters|August 10, 2011
Substitution of the phosphonic acid and hydroxamic acid functionalities of the DXR inhibitor FR900098: an attempt to improve the activity against Mycobacterium tuberculosisMounir Andaloussi, Martin Lindh, Christofer Björkelid, et al.
Journal of Medicinal Chemistry|February 29, 2012
Trisubstituted imidazoles as Mycobacterium tuberculosis glutamine synthetase inhibitorsJohan Gising, Mikael T Nilsson, Luke R Odell, et al.
Journal of Medicinal Chemistry|June 18, 2011
Design, synthesis, and X-ray crystallographic studies of α-aryl substituted fosmidomycin analogues as inhibitors of Mycobacterium tuberculosis 1-deoxy-D-xylulose 5-phosphate reductoisomeraseMounir Andaloussi, Lena M Henriksson, Anna Więckowska, et al.
Journal of Medicinal Chemistry|July 4, 2013
DXR inhibition by potent mono- and disubstituted fosmidomycin analoguesAnna M Jansson, Anna Więckowska, Christofer Björkelid, et al.
Pageof 1